Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972439 · ClinicalTrials.gov registry record · NA
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
A NA study of Oral Contraceptive, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT00972439 is a NA study of Oral Contraceptive that has completed, run by University of Southern California. The registered enrollment target is 33 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00972439, a NA study of Oral Contraceptive, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill). Some research indicates that women who use birth control pills with lower amounts of progestin (a hormone in the birth control pill) may have lower breast cell growth than women who use birth control pills with a higher amount of progestin; this research will examine that in detail.
Conditions Studied
Interventions
- DRUG Oral Contraceptive: Ortho-Novum® 1/35
- DRUG Oral Contraceptive: Ovcon Fe®
Study Locations (1)
California
- Los Angeles County Hospital - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00972439
The ClinicalTrials.gov registry entry for NCT00972439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oral Contraceptive appearing as the primary indexed condition, and to 2 interventions - of which Oral Contraceptive: Ortho-Novum® 1/35 is the first listed.
NCT00972439 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00972439 about?
NCT00972439 is a clinical study titled "Oral Contraceptive (OC) Progestin Dose and Breast Proliferation". The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill). Some research indicates that women who use birth control pills with lower amounts of progestin (a hormone in the birth contro...
What is the current status of trial NCT00972439?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2007-08. Estimated completion is 2008-11.
What conditions does trial NCT00972439 study?
This clinical trial studies the following conditions: Oral Contraceptive.
What interventions are being tested in trial NCT00972439?
The interventions under investigation include: Oral Contraceptive: Ortho-Novum® 1/35 (DRUG), Oral Contraceptive: Ovcon Fe® (DRUG).
Who is sponsoring clinical trial NCT00972439?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00972439 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.